Hello, I am Dr. Hidenori Shimada of Grand Green Osaka Umekita Clinic in Osaka, Japan.
Why people ask about combining NK cell therapy with standard cancer treatment
For many international patients, the first question is not whether to choose an immune-based option, but whether it can sit alongside the treatment already planned by their oncologist. Surgery, chemotherapy and radiation therapy remain the foundation of cancer care, and nothing about NK cell therapy is meant to replace them. The more practical question is how the two might be coordinated.
At Grand Green Osaka Umekita Clinic in Umeda, Osaka, NK cell therapy is described as a cancer immune cell therapy that uses your own cells. According to the clinic’s treatment information, it is not expected to interfere with surgery, chemotherapy or radiation therapy, so it may be considered alongside them. This article explains what that statement means in everyday terms, and which questions are worth raising with your doctors before you decide.
A quick refresher: what NK cell therapy involves
NK (natural killer) cells are innate immune cells that circulate in the blood and can recognise and attack abnormal cells, including cancer cells and virus-infected cells, without waiting for instructions from other immune cells. Their activity is reported to decline with age, stress and the effects of cancer itself.
In NK cell therapy, NK cells are obtained from a standard blood draw. They are then activated and expanded at a specialised cell processing facility and returned to your body by intravenous infusion. Because the cells come from you, the approach is called autologous. The aim is to return NK cells that are greater in number and higher in activity, with the intention of reinforcing immune function. It is important to understand that this is an aim, not a promised outcome, and individual responses vary.
Treatment consists of a blood draw and an infusion. It does not require hospitalisation, which is one reason many people consider it as an outpatient option that can fit around other appointments.
How NK cell therapy can be thought of alongside surgery, chemotherapy and radiation
Standard treatments act on cancer in different ways. Surgery removes tumours, radiation delivers energy to a targeted area, and chemotherapy uses medicines that travel through the body. NK cell therapy takes a different route: it works through the immune system rather than directly removing or damaging tumour tissue.
Because of this difference, the clinic describes the therapy as something that can be used together with standard treatment rather than instead of it. In practice, though, timing matters. Chemotherapy and radiation can affect blood counts and general condition, and the schedule for blood collection and infusion needs to take that into account. These are decisions for physicians, not something a general article can settle for you.
If you are in the middle of treatment, a sensible approach is to ask your oncologist how they view the idea before you book anything. Your own treatment team knows your diagnosis, your test results and your planned schedule, and their view should carry real weight.
Coordinating with your home oncologist from overseas
Many international patients continue their main cancer care in their home country. Grand Green Osaka Umekita Clinic states that it can coordinate with the medical institution providing your standard treatment. For a patient travelling from abroad, that usually means preparing information in advance so that both teams are working from the same picture.
Useful items to gather include your diagnosis and stage, a summary of treatments completed and planned, recent blood test results, current medications and any history of allergies or infections. Having documents in English, or accompanied by a translation, helps the consultation go more smoothly. The clinic also offers information pages for international patients, so you can review the general flow before contacting them.
It can also help to ask your home oncologist two simple questions: whether they have any concerns about adding an immune cell therapy to your plan, and whether there are periods in your schedule when they would prefer that nothing new be introduced. Their answers can then be shared with the clinic in Osaka.
What to ask a doctor before deciding
A consultation is where the real assessment takes place. Whether NK cell therapy is suitable for you depends on your condition, your current treatment and your overall health, and only a doctor who has examined you can judge that. The following questions can help you prepare.
- Given my diagnosis and current treatment plan, is NK cell therapy a reasonable option to discuss?
- How would blood collection and infusions be scheduled around my surgery, chemotherapy or radiation?
- What temporary effects, such as fever or fatigue, might I experience, and how are they managed?
- What are the limits of this therapy, and what is not known about its effect in my situation?
- What are the total costs, the number of treatments and the expected duration?
It is reasonable to expect straightforward answers, including honest statements about uncertainty. A good consultation should leave you better informed, not pressured.
Self-pay treatment, legal framework and practical points for travellers
NK cell therapy at the clinic is self-pay medicine, which means it is not covered by Japan’s public health insurance. Costs, the number of treatments and the treatment period should be confirmed directly with the clinic during consultation. Please check the fees section of the treatment page rather than relying on figures quoted elsewhere.
In Japan, cell therapies of this kind are provided under the country’s regenerative medicine law. The clinic states that treatment is offered under a regenerative medicine provision plan that has been submitted to and accepted by the national authorities. This framework governs how cells are handled and how treatment is delivered, and it is a reasonable topic to raise with your doctor if you want to understand how oversight works.
Finally, remember the realistic limits. Immune cell therapy is not a guarantee of any particular result, and it is not a reason to delay or skip the treatment recommended by your oncologist. If you are considering travelling to Osaka, plan your visit with your home medical team in mind, and use the consultation to confirm whether the therapy is appropriate before committing to any schedule.
- Standard care stays centralNot replaced by NK cells
- Your own NK cellsBlood draw and IV infusion
- Share your recordsCoordinate with home oncologist
- Doctor consultation firstCosts and risks confirmed
This figure is a conceptual summary of the article content
References
Supervising Physician
Director, Medical Corporation Shimada Clinic
Head of Clinical Practice, Grand Green Osaka Umekita Clinic
Hidenori Shimada
Graduated from the University of Tokushima Faculty of Medicine in 2005. After his initial residency, he obtained U.S. medical certification (ECFMG) and trained as a sub-intern in general surgery at the University of Washington. After completing the doctoral program at Kyoto University Graduate School of Medicine and working as a researcher at the Center for iPS Cell Research and Application (CiRA), Kyoto University, he founded Shimada Clinic in 2013. At Grand Green Osaka Umekita Clinic (https://umekitaclinic.org), he is engaged in a wide range of care, from internal medicine and pediatrics to cell therapy and aesthetic medicine.
* The physician supervision of this article covers its academic content only and does not constitute a recommendation of any specific treatment or product.